GI Effects® Comprehensive Profile - Stool

The GI Effects® Comprehensive Profile is unlike any other stool analysis profile, going beyond the standard parameters for identifying gastrointestinal disorders.

Video: Introducing the GI Effects 2200

The GI Effects® Comprehensive Profile uses the best of both culture-based and molecular approaches for stool-based gastrointestinal diagnostics. O&P technology can identify an unlimited number of parasites and is the gold standard diagnostic methodology for parasite detection, while PCR technology provides an expansive assessment of anaerobic gut microflora.

Advantages of the GI Effects Stool Profile

  • Enhanced Clinical Utility
    Clinical utility for parasite detection is enhanced with O&P technology, the current clinical diagnostic standard of care. Optimized Parasite Recovery (OPR) is Genova Diagnostics’ version of O&P technology which utilizes a concentration process to optimize parasite detection. Because the vast majority of commensal gut microflora are anaerobes that present culture challenges, microbial DNA analysis is utilized to optimize the assessment of gut microbial composition.
  • 1-Day or 3-Day Sample Collection Option
    Parasite Recovery Literature suggests that >90% of enteric parasitic infections are detected in a sample from a single stool collection. Increased recovery results from the collection of additional specimens on separate days, and given that, scientific bodies such as the Centers for Disease Control recommend a minimum of three samples on three separate days to optimize parasite detection.

Why Use Stool Analysis?

Gastrointestinal function is important for general health. The intestinal tract contains significant amounts of bacteria which, when imbalanced, have been associated with IBS and IBD, immune disorders, diabetes, and cardiovascular disease. Balancing gut microflora is key for optimizing digestion and absorption of nutrients, as well as metabolic functions. Poor digestion and malabsorption can lead to immune dysfunction, nutritional insufficiencies, mental/emotional disorders, and autoimmune diseases.

  • Anaerobes
    Anaerobes, making up over 95 percent of microbiota in the gut, can be identified using GI Effects®.
  • Parasites
    Using O&P (OPR) technology, an unlimited number of parasites can be detected. To date, over 40 parasitic organisms have been identified.
  • Adiposity Index
    Measures imbalances of the two predominant bacterial groups in the human GI tract, bacteroidetes and firmicutes, which have been associated with obesity in some studies.
  • Absorption
    Indicates absorption issues with elevated levels of long-chain fatty acids, cholesterol, or total fat (the sum of gut lipids).
  • Inflammation
    Lactoferrin is a marker of gut immune function, and is clinically utilized to identify the presence of gastrointestinal inflammation.
  • Sensitivities
    Pharmaceutical and botanical sensitivities are included.

Test name(s)

GI Effects® 2200: Comprehensive Profile (Includes 2205, 2110, and 2120)*

*Not Available in New York

Method: Microscopic examination, Macroscopic evaluation, EIA, PCR, GC/MS, HPLC, Automated Chemistry, Colorimetric

Pathogens (C. difficile, H. pylori, Shiga Toxin E. coli, and Campylobacter spp) (Available as EIA add-ons)


  • Acetate
  • Acetate %
  • Achromobacter/Alcaligenes spp.
  • Aeromonas spp.
  • Ancylostoma-Necator Sp.
  • Ascaris lumbricoides
  • Bacillus spp.
  • Bacteroides spp.
  • Bacteroidetes
  • Balantidium Coli
  • Bifidobacter spp.
  • Blastocystis hominis
  • Butyrate %
  • Candida spp.
  • Charcot-leyden crystals
  • Chilomastix mesnilli
  • Cholesterol
  • Citrobacter spp.
  • Clonorchis sinensis
  • Clostridia spp.
  • Color
  • Cyclospora ceyatanensis
  • Dientamoeba fragilis
  • Diphyllobothrium latum
  • Echinococcus granulosus
  • Echinococcus multi-locularis
  • Elastase 1
  • Endolimax nana
  • Entamoeba coli
  • Entamoeba hartmani
  • Entamoeba histolytica/dispar
  • Enterobacter spp.
  • Enterobius vermicularis
  • Enteromonis hominis
  • Escherichia coli
  • Fasciola hepatica
  • Fasciolopsis buski
  • Fecal sIgA
  • Firmicutes
  • Fusobacteria spp.
  • Geotrichum spp.
  • Giardia lamblia
  • Hymenopelis diminuta
  • Hymenopolis nana
  • Iodamoeba beutschlii
  • Isospora belli
  • Klebsiella oxytoca
  • Klebsiella pneumoniae
  • LCFAs
  • Lactobacillus spp.
  • Lactoferrin
  • Metagonimus yokogawai
  • Morganella morganii
  • Mucus
  • Mycoplasma spp.
  • No ova or parasites seen
  • Paragonimus westermani
  • Prevotella spp.
  • Propionate
  • Propionate %
  • Pseudomonas spp.
  • Putrefactive SCFA
  • RBCs
  • Retortamonas hominis
  • Rhodotorula spp.
  • Saccharomyces spp.
  • Salmonella spp.
  • Schistosoma haematobium
  • Schistosoma japonicum
  • Schistosoma mansoni
  • Schistosoma mekongi
  • Staphylococcus aureus
  • Streptomyces spp.
  • Strongyloides stercoralis
  • Taenia sp.
  • Taxonomy Unknown
  • Total Fat
  • Total SCFA
  • Toxocara sp.
  • Trichomonas hominis
  • Trichuris trichiura
  • Triglycerides
  • Valerate %
  • Vegetable Fibers
  • Vibrio spp.
  • WBCs
  • Yersinia spp.
  • i-Butyrate
  • i-Valerate
  • n-Butyrate
  • n-Valerate
  • pH

Turn Around Time: 

17 Days

© 1998 - 2014 Genova Diagnostics (GDX)
This website is intended for educational purposes only. It is not meant for use as diagnostic information and is part of Genova Diagnostics' communication with physicians and patients.